Kyoto, Japan

Takashi Okubo

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Nippon Shinyaku Company, Ltd.. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Okubo. Retrieved from https://idiyas.com/inventor/takashi-okubo-28ws5o2p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takashi Okubo: Innovator in Pharmaceutical Chemistry

Introduction

Takashi Okubo is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of adrenergic blocking agents. His work has implications for both human and animal health.

Latest Patents

Okubo holds a patent for a compound known as 1-phenoxy-3-(4-phenylpiperidino)-2-propan and its derivatives. This invention includes both alpha- and beta-adrenergic blocking agents, which are useful for their hypotensive activity. The patent outlines the chemical structure and potential applications of these compounds, emphasizing their therapeutic benefits.

Career Highlights

Throughout his career, Takashi Okubo has been associated with Nippon Shinyaku Company, Ltd. His work at this esteemed organization has allowed him to focus on innovative pharmaceutical solutions. His research has contributed to advancements in drug development and therapeutic applications.

Collaborations

Okubo has collaborated with notable colleagues, including Yoshiaki Aoyagi and Toshio Tomita. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Takashi Okubo's contributions to pharmaceutical chemistry and his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the field positively, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…